SNY

Sanofi ADS
D

SNY

Arincen75/100B

Sanofi ADS operating income 1999–2026

Sanofi ADS's operating income in Q3 FY2026, the three months to 30 September 2026, was 4.71B EUR, up 29.9% on the same quarter a year before. Sanofi ADS's operating income over the last twelve months was 8.32B EUR, up 5.3% on the twelve months before. In fiscal year 2025 it was 9.60B EUR, up 32.3% on the year before.

Last updated 9 Nov 2026 · Next report 4 Feb 2027

Operating income

Operating income · +5.5% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 20268.32B+5.28%16.32%37.57B73.68%15.56B
FY202531 Dec 20259.60B+32.34%20.54%33.67B72.07%12.48B
FY202431 Dec 20247.25B+4.20%16.38%31.08B70.18%11.03B
FY202331 Dec 20236.96B-31.51%16.72%28.99B69.66%11.39B
FY202231 Dec 202210.16B+25.06%25.05%28.68B70.71%13.51B
FY202131 Dec 20218.13B-42.42%20.74%26.92B68.72%11.54B
FY202031 Dec 202014.11B+362.57%37.77%25.21B67.46%17.53B
FY201931 Dec 20193.05B-34.75%8.11%25.65B68.17%10.66B
FY201831 Dec 20184.68B-19.43%13.11%24.24B67.95%9.18B
FY201731 Dec 20175.80B-11.13%16.02%24.61B67.94%9.64B
FY201631 Dec 20166.53B+16.13%18.82%24.00B69.16%9.90B
FY201531 Dec 20155.62B-7.26%16.13%23.94B68.68%10.08B
FY201431 Dec 20146.06B+21.72%18.95%21.77B68.03%9.54B
FY201331 Dec 20134.98B-22.52%15.92%20.99B67.08%10.19B
FY201231 Dec 20126.43B+9.71%17.88%24.86B69.14%11.43B
FY201131 Dec 20115.86B-10.31%16.72%24.19B69.01%11.55B
FY201031 Dec 20106.54B+2.65%19.20%24.64B72.39%11.77B
FY200931 Dec 20096.37B+44.88%20.70%22.87B74.37%11.40B
FY200831 Dec 20084.39B-25.66%15.25%21.48B74.54%10.48B
FY200731 Dec 20075.91B+3.18%20.24%21.64B74.08%10.77B
FY200631 Dec 20065.73B+20.63%19.43%21.90B74.27%12.12B
FY200531 Dec 20054.75B+63.90%16.67%20.93B73.47%11.67B
FY200431 Dec 20042.90B-5.61%18.43%11.29B71.79%5.82B
FY200331 Dec 20033.07B+17.35%38.21%6.61B82.26%3.46B
FY200231 Dec 20022.62B+24.21%35.09%6.08B81.50%3.00B
FY200131 Dec 20012.11B+33.54%32.46%5.24B80.69%2.41B
FY200031 Dec 20001.58B+62.41%26.45%4.52B75.82%1.82B
FY199931 Dec 1999971.00M—18.15%3.74B69.98%1.21B

Figures in EUR. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Sanofi ADS's operating income

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.